Category: Prosigna

Don’t miss this webinar on genomic profiling in early breast cancer

Upcoming Webinar: Genomic Profiles and the Future of Early Breast Cancer Care Date: 25th September 2020     Time: 4.00pm (CEST)  Register now for this upcoming webinar sponsored by our laboratory partner, Veracyte to hear the latest evidence on the clinical utility of the Prosigna® breast cancer prognostic gene signature to support shared treatment decisions. Hear… Read more »

Prognostic testing: How Prosigna can help to prioritise patients for chemotherapy during the coronavirus pandemic

The implications of coronavirus on the treatment of cancer patients in the UK is still unknown. As you will be aware, NHS England has issued two sets of guidance notes on this matter (guidance notes available on NHS England website. These documents clearly prioritise surgical, chemotherapy and radiotherapy procedures into different priority bands. With regard… Read more »